BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angerilli V, Galuppini F, Pagni F, Fusco N, Malapelle U, Fassan M. The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization. Diagnostics (Basel) 2021;11:339. [PMID: 33670699 DOI: 10.3390/diagnostics11020339] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Hofman P, Calin GA, Mani SA, Bontoux C, Ilié M, Wistuba II. The Third Joint Meeting on Lung Cancer of the FHU OncoAge (University Côte d'Azur, Nice, France) and the University of Texas MD Anderson Cancer Center (Houston, TX, USA). Understanding New Therapeutic Options and Promising Predictive Biomarkers for Lung Cancer Patients. Cancers (Basel) 2022;14:4327. [PMID: 36077862 DOI: 10.3390/cancers14174327] [Reference Citation Analysis]
2 Bonizzi G, Zattoni L, Capra M, Cassi C, Taliento G, Ivanova M, Guerini-rocco E, Fumagalli M, Monturano M, Albini A, Viale G, Orecchia R, Fusco N. Standard operating procedures for biobank in oncology. Front Mol Biosci 2022;9:967310. [DOI: 10.3389/fmolb.2022.967310] [Reference Citation Analysis]
3 Ceccon C, Angerilli V, Rasola C, Procaccio L, Sabbadin M, Bergamo F, Malapelle U, Lonardi S, Fassan M. Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches. Front Oncol 2022;12:930108. [DOI: 10.3389/fonc.2022.930108] [Reference Citation Analysis]
4 Zannoni GF, Santoro A, D'Alessandris N, Scaglione G, Inzani F, Angelico G, Bragantini E, Piermattei A, Cianfrini F, Bisaro B, Fassan M; Members of PAGINE (SIAPEC) - Collaborators. Biomarker characterization in endometrial cancer in Italy: first survey data analysis. Pathologica 2022;114:189-98. [PMID: 35775705 DOI: 10.32074/1591-951X-775] [Reference Citation Analysis]
5 Cappello F, Angerilli V, Munari G, Ceccon C, Sabbadin M, Pagni F, Fusco N, Malapelle U, Fassan M. FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint. JPM 2022;12:750. [DOI: 10.3390/jpm12050750] [Reference Citation Analysis]
6 Fusco N, Rizzo A, Costarelli L, Santinelli A, Cerbelli B, Scatena C, Macrì E, Pietribiasi F, d’Amati G, Sapino A, Castellano I. Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC). Pathologica 2022. [DOI: 10.32074/1591-951x-747] [Reference Citation Analysis]
7 Venetis K, Crimini E, Sajjadi E, Corti C, Guerini-rocco E, Viale G, Curigliano G, Criscitiello C, Fusco N. HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer. Front Mol Biosci 2022;9:834651. [DOI: 10.3389/fmolb.2022.834651] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
8 Iaccarino A, Acanfora G, Pisapia P, Malapelle U, Bellevicine C, Troncone G, Vigliar E. Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience. JMP 2022;3:15-23. [DOI: 10.3390/jmp3010002] [Reference Citation Analysis]
9 Venetis K, Fusco N, Sajjadi E. Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients. Front Oncol 2021;11:735476. [PMID: 34660298 DOI: 10.3389/fonc.2021.735476] [Reference Citation Analysis]
10 Salati M, Venetis K, Fassan M, Malapelle U, Pagni F, Sajjadi E, Fusco N, Ghidini M. ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality. Future Oncol 2021;17:4607-18. [PMID: 34406032 DOI: 10.2217/fon-2021-0228] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Angerilli V, Fontana E, Lonardi S, Sbaraglia M, Borelli B, Munari G, Salmaso R, Guzzardo V, Spolverato G, Pucciarelli S, Pilati P, Hahne JC, Bergamo F, Zagonel V, Dei Tos AP, Sadanandam A, Loupakis F, Valeri N, Fassan M. Intratumor morphologic and transcriptomic heterogeneity in V600EBRAF-mutated metastatic colorectal adenocarcinomas. ESMO Open 2021;6:100211. [PMID: 34271310 DOI: 10.1016/j.esmoop.2021.100211] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Fusco N, Marchiò C, Ghidini M, Scatena C. Special Issue: Molecular Biomarkers in Solid Tumors. Genes (Basel) 2021;12:984. [PMID: 34203156 DOI: 10.3390/genes12070984] [Reference Citation Analysis]
13 Hofman P. What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy. JMP 2021;2:147-72. [DOI: 10.3390/jmp2020015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Sajjadi E, Venetis K, Piciotti R, Invernizzi M, Guerini-Rocco E, Haricharan S, Fusco N. Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization. Cancer Cell Int 2021;21:266. [PMID: 34001143 DOI: 10.1186/s12935-021-01976-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Piciotti R, Venetis K, Sajjadi E, Fusco N. Mismatch Repair Status Characterization in Oncologic Pathology: Taking Stock of the Real-World Possibilities. JMP 2021;2:93-100. [DOI: 10.3390/jmp2020009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]